Terms: = Lung cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3 AND Treatment
11 results:
1. CIC-DUX4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract] [Full Text] [Related]
2. etv4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2.
Cheng T; Zhang Z; Cheng Y; Zhang J; Tang J; Tan Z; Liang Z; Chen T; Liu Z; Li J; Zhao J; Zhou R
Biochem Biophys Res Commun; 2019 Aug; 516(1):278-284. PubMed ID: 31253395
[TBL] [Abstract] [Full Text] [Related]
3. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract] [Full Text] [Related]
4. FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
Schelch K; Wagner C; Hager S; Pirker C; Siess K; Lang E; Lin R; Kirschner MB; Mohr T; Brcic L; Marian B; Holzmann K; Grasl-Kraupp B; Krupitza G; Laszlo V; Klikovits T; Dome B; Hegedus B; Garay T; Reid G; van Zandwijk N; Klepetko W; Berger W; Grusch M; Hoda MA
Carcinogenesis; 2018 Apr; 39(4):534-545. PubMed ID: 29635378
[TBL] [Abstract] [Full Text] [Related]
5. Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer.
Harding TC; Long L; Palencia S; Zhang H; Sadra A; Hestir K; Patil N; Levin A; Hsu AW; Charych D; Brennan T; Zanghi J; Halenbeck R; Marshall SA; Qin M; Doberstein SK; Hollenbaugh D; Kavanaugh WM; Williams LT; Baker KP
Sci Transl Med; 2013 Mar; 5(178):178ra39. PubMed ID: 23536011
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptional regulatory networks in human lung adenocarcinoma.
Meng X; Lu P; Bai H; Xiao P; Fan Q
Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
[TBL] [Abstract] [Full Text] [Related]
7. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
[TBL] [Abstract] [Full Text] [Related]
8. Simvastatin downregulates HER2 via upregulation of pea3 to induce cell death in HER2-positive breast cancer cells.
Zhao Z; Cao X; Pan Y; Sha S; Zhao T; Zhang T
Oncol Res; 2012; 20(5-6):187-95. PubMed ID: 23581225
[TBL] [Abstract] [Full Text] [Related]
9. e1af/pea3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract] [Full Text] [Related]
10. Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells.
Shibakura M; Niiya K; Kiguchi T; Kitajima I; Niiya M; Asaumi N; Huh NH; Nakata Y; Harada M; Tanimoto M
Int J Cancer; 2003 Jan; 103(3):380-6. PubMed ID: 12471621
[TBL] [Abstract] [Full Text] [Related]
11. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract] [Full Text] [Related]
